In the News
-
HG Shire Announces FDA Approval for Type 1 Gaucher Disease
08 November 2011
HG Shire Announces FDA Approval of VPRIVTM (velaglucerase alfa for injection) for the Treatment of Type 1 Gaucher Disease Click here to see...
Read more....
-
Protalix Submits Reply to FDA Complete Response Letter for Taliglucerase Alfa and Reports Top-Line Results from the Company's Switchover Trial
07 November 2011
CARMIEL, Israel, Aug. 1, 2011 Protalix BioTherapeutics, Inc. (nyse-amex:PLX)(tase:PLX), announced today that it has submitted its reply to th...
Read more....
-
Gauchers Association moves into new offices
21 September 2011
We are pleased to announce that as of the 12th September The Gauchers Association moved their office into new premises. Our new address is: Evesham...
Read more....
-
Protalix BioTherapeutics
11 September 2011
CARMIEL, Israel, September 8, 2011 /PR Newswire/Protalix BioTherapeutics, Inc. (NYSE-AMEX:PLX, TASE:PLX), today announced that an article entitled "Pi...
Read more....
-
Gaucher's Cycle Ride
24 July 2011
Gaucher’s Bike Ride London – Cambridge on Sunday 4th September 2011 Back by popular demand Start: University College School Playing Fields, R...
Read more....
-
Genzyme Celebrates 20th Anniversary of Gaucher Disease Registry with Launch of New Web Platform
19 July 2011
20.06.11 “RegistryNXT!” builds upon largest resource in the world for Gaucher disease data CAMBRIDGE, Mass.--(BUSINESS...
Read more....
-
Pascal is now ADMIN... YIPPPY YEAH!!!
11 July 2011
now working on the website... so good so great ....!!!!
Read more....
-
New EGA Website launched
26 May 2011
The European Gaucher Alliance are delighted to announce the launch of our new website resource. The new site contains a wealth of information with reg...
Read more....
-
Shire launch new information website on Gaucher disease
26 May 2011
This website has been developed for patients, carers and their families, it provides information on VPRIV the enzyme replacement therapy for Type I...
Read more....
-
The LSD Adult Service Birmingham - Launch Meeting
14 February 2011
The Queen Elizabeth Hospital, part of University Hospitals Birmingham NHS Foundation Trust, would like to announce the launch of the Lysosomal Storage...
Read more....
-
Protalix BioTherapeutics Presents Data on the Company's Fabry Program and Oral Enzyme Gaucher Program With Experts in the Field of Lysosomal Disorders
20 January 2011
CARMIEL, Israel, Protalix BioTherapeutics, Inc. announced today that management presented data on the Company's preclinical Fabry program and oral enz...
Read more....
-
EWGGD 2010 - Cologne
19 January 2011
9th international EWGGD meeting will be held in Cologne 30th June-3rd July 2010. For more information please go to the official site here.
Read more....